questionsmedicales.fr
Hémopathies et maladies lymphatiques
Hémopathies
Troubles hémorragiques
Troubles hémorragiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Troubles de la coagulation
Tests de coagulation
Temps de prothrombine
Temps de thromboplastine partielle activée
Antécédents familiaux
Hémophilie
Saignement
Évaluation clinique
Symptômes
5
Hémorragie interne
Selles sanglantes
Menstruations
Saignement menstruel
Saignement de nez
Troubles hémorragiques
Prévention
5
Prévention
Gestion des risques
Mode de vie
Alimentation équilibrée
Activités sportives
Prévention des blessures
Consultation médicale
Suivi médical
Traitements
5
Transfusion sanguine
Thérapie génique
Hémophilie
Facteurs de coagulation
Anticoagulants
Saignement
Classification des maladies
Traitement
Complications
5
Hémorragie interne
Choc hypovolémique
Qualité de vie
Soins médicaux
Infections
Transfusion sanguine
Gestion des complications
Traitement
Facteurs de risque
5
Antécédents familiaux
Maladies hépatiques
Troubles menstruels
Femmes
Médicaments
Anticoagulants
Maladies auto-immunes
Coagulation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Troubles hémorragiques : Questions médicales les plus fréquentes",
"headline": "Troubles hémorragiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Troubles hémorragiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-25",
"dateModified": "2025-02-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Troubles hémorragiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hémopathies",
"url": "https://questionsmedicales.fr/mesh/D006402",
"about": {
"@type": "MedicalCondition",
"name": "Hémopathies",
"code": {
"@type": "MedicalCode",
"code": "D006402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Troubles de l'hémostase",
"alternateName": "Hemostatic Disorders",
"url": "https://questionsmedicales.fr/mesh/D020141",
"about": {
"@type": "MedicalCondition",
"name": "Troubles de l'hémostase",
"code": {
"@type": "MedicalCode",
"code": "D020141",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.515"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hémangiome caverneux",
"alternateName": "Hemangioma, Cavernous",
"url": "https://questionsmedicales.fr/mesh/D006392",
"about": {
"@type": "MedicalCondition",
"name": "Hémangiome caverneux",
"code": {
"@type": "MedicalCode",
"code": "D006392",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.515.385"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Réaction de Schwartzman",
"alternateName": "Shwartzman Phenomenon",
"url": "https://questionsmedicales.fr/mesh/D012790",
"about": {
"@type": "MedicalCondition",
"name": "Réaction de Schwartzman",
"code": {
"@type": "MedicalCode",
"code": "D012790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.515.810"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie du pool vide",
"alternateName": "Platelet Storage Pool Deficiency",
"url": "https://questionsmedicales.fr/mesh/D010981",
"about": {
"@type": "MedicalCondition",
"name": "Maladie du pool vide",
"code": {
"@type": "MedicalCode",
"code": "D010981",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.735"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thrombocytémie essentielle",
"alternateName": "Thrombocythemia, Essential",
"url": "https://questionsmedicales.fr/mesh/D013920",
"about": {
"@type": "MedicalCondition",
"name": "Thrombocytémie essentielle",
"code": {
"@type": "MedicalCode",
"code": "D013920",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.825"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Troubles hémorragiques",
"alternateName": "Hemorrhagic Disorders",
"code": {
"@type": "MedicalCode",
"code": "D006474",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Avrey Thau",
"url": "https://questionsmedicales.fr/author/Avrey%20Thau",
"affiliation": {
"@type": "Organization",
"name": "Thomas Jefferson University, Philadelphia, PA, USA."
}
},
{
"@type": "Person",
"name": "Brooke Saffren",
"url": "https://questionsmedicales.fr/author/Brooke%20Saffren",
"affiliation": {
"@type": "Organization",
"name": "Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA."
}
},
{
"@type": "Person",
"name": "James D Anderst",
"url": "https://questionsmedicales.fr/author/James%20D%20Anderst",
"affiliation": {
"@type": "Organization",
"name": "Division of Child Adversity and Resilience, Children's Mercy Hospital, Kansas City, MO, USA."
}
},
{
"@type": "Person",
"name": "Shannon L Carpenter",
"url": "https://questionsmedicales.fr/author/Shannon%20L%20Carpenter",
"affiliation": {
"@type": "Organization",
"name": "Department of Hematology, Oncology, and Bone Marrow Transplantation, Children's Mercy Hospital, Kansas City, MO, USA."
}
},
{
"@type": "Person",
"name": "Thibault Coste",
"url": "https://questionsmedicales.fr/author/Thibault%20Coste",
"affiliation": {
"@type": "Organization",
"name": "AP-HP, Service de génétique moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Yellow Fever: A Perennial Threat.",
"datePublished": "2022-10-28",
"url": "https://questionsmedicales.fr/article/36404585",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.arcmed.2022.10.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "A High-Throughput Yellow Fever Neutralization Assay.",
"datePublished": "2022-06-07",
"url": "https://questionsmedicales.fr/article/35670599",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/spectrum.02548-21"
}
},
{
"@type": "ScholarlyArticle",
"name": "Laboratory evaluation of RealStar Yellow Fever Virus RT-PCR kit 1.0 for potential use in the global yellow fever laboratory network.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/36067233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pntd.0010770"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV.",
"datePublished": "2023-08-23",
"url": "https://questionsmedicales.fr/article/37650759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/QAD.0000000000003696"
}
},
{
"@type": "ScholarlyArticle",
"name": "Malaria transmission in Africa: Its relationship with yellow fever and measles.",
"datePublished": "2022-05-04",
"url": "https://questionsmedicales.fr/article/35507574",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0268080"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Hémopathies et maladies lymphatiques",
"item": "https://questionsmedicales.fr/mesh/D006425"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hémopathies",
"item": "https://questionsmedicales.fr/mesh/D006402"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles hémorragiques",
"item": "https://questionsmedicales.fr/mesh/D006474"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Troubles hémorragiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Troubles hémorragiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Troubles hémorragiques",
"description": "Comment diagnostiquer un trouble hémorragique ?\nQuels tests sont utilisés pour évaluer la coagulation ?\nLes antécédents familiaux sont-ils importants ?\nComment évaluer la gravité d'un saignement ?\nLes examens d'imagerie sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Yellow+Fever#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Troubles hémorragiques",
"description": "Quels sont les symptômes courants des troubles hémorragiques ?\nComment reconnaître une hémorragie interne ?\nLes saignements menstruels peuvent-ils indiquer un trouble ?\nQuelles sont les manifestations cutanées des troubles hémorragiques ?\nLes saignements de nez sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Yellow+Fever#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Troubles hémorragiques",
"description": "Comment prévenir les troubles hémorragiques ?\nLes vaccinations sont-elles importantes ?\nLe mode de vie influence-t-il ces troubles ?\nLes activités sportives doivent-elles être évitées ?\nLes consultations médicales régulières sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Yellow+Fever#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Troubles hémorragiques",
"description": "Quels traitements sont disponibles pour les troubles hémorragiques ?\nComment traiter l'hémophilie ?\nLes anticoagulants sont-ils utilisés dans ces troubles ?\nQuelles sont les options pour les saignements sévères ?\nLes traitements varient-ils selon le type de trouble ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Yellow+Fever#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Troubles hémorragiques",
"description": "Quelles complications peuvent survenir ?\nLes troubles hémorragiques peuvent-ils être mortels ?\nComment les troubles hémorragiques affectent-ils la qualité de vie ?\nLes troubles hémorragiques augmentent-ils le risque d'infections ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Yellow+Fever#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Troubles hémorragiques",
"description": "Quels sont les facteurs de risque des troubles hémorragiques ?\nL'âge influence-t-il le risque ?\nLes femmes sont-elles plus à risque ?\nLes médicaments peuvent-ils augmenter le risque ?\nLes maladies auto-immunes sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Yellow+Fever#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble hémorragique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des antécédents médicaux, des tests de coagulation et des analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la coagulation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests courants incluent le temps de prothrombine (TP) et le temps de thromboplastine partielle activée (TTPa)."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles hémorragiques peuvent indiquer une prédisposition génétique."
}
},
{
"@type": "Question",
"name": "Comment évaluer la gravité d'un saignement ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gravité est évaluée par la quantité de sang perdu et l'impact sur la santé générale du patient."
}
},
{
"@type": "Question",
"name": "Les examens d'imagerie sont-ils nécessaires ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Parfois, des examens d'imagerie comme l'échographie peuvent être nécessaires pour détecter des hématomes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles hémorragiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des saignements fréquents, des ecchymoses, et des saignements des gencives."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hémorragie interne ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs abdominales, des vertiges, et des selles noires ou sanglantes."
}
},
{
"@type": "Question",
"name": "Les saignements menstruels peuvent-ils indiquer un trouble ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des menstruations excessives peuvent signaler un trouble hémorragique sous-jacent."
}
},
{
"@type": "Question",
"name": "Quelles sont les manifestations cutanées des troubles hémorragiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des ecchymoses, des pétéchies et des saignements sous-cutanés peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les saignements de nez sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les saignements de nez récurrents peuvent être un symptôme de troubles hémorragiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles hémorragiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un diagnostic précoce, une gestion des facteurs de risque et des soins appropriés."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent prévenir des infections qui aggravent les troubles hémorragiques."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il ces troubles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant une alimentation équilibrée, peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les activités sportives doivent-elles être évitées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines activités à risque doivent être évitées pour prévenir les blessures et les saignements."
}
},
{
"@type": "Question",
"name": "Les consultations médicales régulières sont-elles nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des consultations régulières aident à surveiller et à gérer les troubles hémorragiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles hémorragiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des transfusions sanguines, des médicaments et des thérapies géniques."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hémophilie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hémophilie est traitée par des facteurs de coagulation administrés par voie intraveineuse."
}
},
{
"@type": "Question",
"name": "Les anticoagulants sont-ils utilisés dans ces troubles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les anticoagulants peuvent aggraver les saignements et ne sont pas recommandés."
}
},
{
"@type": "Question",
"name": "Quelles sont les options pour les saignements sévères ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments hémostatiques et, dans certains cas, une intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type de trouble ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement dépend du type spécifique de trouble hémorragique et de sa gravité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des hémorragies internes, des chocs hypovolémiques et des infections."
}
},
{
"@type": "Question",
"name": "Les troubles hémorragiques peuvent-ils être mortels ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements non contrôlés peuvent entraîner des complications graves et potentiellement mortelles."
}
},
{
"@type": "Question",
"name": "Comment les troubles hémorragiques affectent-ils la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter les activités quotidiennes et nécessiter des soins médicaux fréquents."
}
},
{
"@type": "Question",
"name": "Les troubles hémorragiques augmentent-ils le risque d'infections ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements comme les transfusions peuvent augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par une gestion proactive et un traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des troubles hémorragiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies hépatiques et certains médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de troubles hémorragiques augmente avec l'âge en raison de la dégradation des fonctions corporelles."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines conditions, comme les troubles menstruels, peuvent augmenter le risque chez les femmes."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils augmenter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments, comme les anticoagulants, peuvent augmenter le risque de saignement."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter la coagulation et augmenter le risque de saignement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 19/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Thomas Jefferson University, Philadelphia, PA, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
Division of Child Adversity and Resilience, Children's Mercy Hospital, Kansas City, MO, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, Oncology, and Bone Marrow Transplantation, Children's Mercy Hospital, Kansas City, MO, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
AP-HP, Service de génétique moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France.
Université de Paris, INSERM UMR-1141 Neurodiderot, Paris, France.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
AP-HP, Service de génétique moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France.
Université de Paris, INSERM UMR-1141 Neurodiderot, Paris, France.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics & Gynecology, ChristianaCare, Newark, Delaware.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, Italy. sergiobagnato@gmail.com.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Molecular Biology Laboratory, Giuseppe Giglio Foundation, Cefalù, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Cardinal Ferrari Center, Fontanellato, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
RAN (Research in Advanced Neuro-Rehabilitation), S. Anna Institute, Crotone, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Neurorehabilitation and Spinal Units, ICS Maugeri, Institute of Pavia, Pavia, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Montecatone Rehabilitation Institute, Imola, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Clinical Pathology Laboratory, Provincial Health Authority of Caltanissetta, Caltanissetta, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Department of Ophthalmology, Hallym University Dongtan Sacred Heart Hospital, Hallym University Medical Center, Hwaseong-si, Gyeonggi-do, Republic of Korea.
Publications dans "Troubles hémorragiques" :
Despite the availability of a safe and effective vaccine, yellow fever remains a major vaccine-preventable disease in endemic regions. Additionally, travelers risk acquiring yellow fever when visiting...
Quick and accurate detection of neutralizing antibodies (nAbs) against yellow fever is essential in serodiagnosis during outbreaks for surveillance and to evaluate vaccine efficacy in population-wide ...
Early detection of human yellow fever (YF) infection in YF-endemic regions is critical to timely outbreak mitigation. African National Laboratories chiefly rely on serological assays that require conf...
Specific objectives were to assess the assay's ability to detect YF virus strains in human serum from YF-endemic regions, determine the potential for interference and cross-reactions, verify the perfo...
The RealStar Yellow Fever Virus RT-PCR kit 1.0 has performance characteristics consistent with the manufacturer's claims and is suitable for use in YF-endemic regions. Its use is expected to decrease ...
To evaluate immunogenicity and reactogenicity of yellow fever (YF) vaccine in people with HIV (PWH) compared to HIV-uninfected controls....
In this longitudinal interventional trial (NCT03132311), PWH with CD4 + cell count ≥200 cells/μl and controls, aged 18-59, without a previous history of YF vaccination received a single standard dose ...
YF-neutralization titers were measured at Days 0, 30 and Year 1 and geometric mean titers (GMT) were calculated. Adverse events (AE) and YF virus detection were measured at Days 5 and 30. Linear regre...
Two hundred and eighteen PWH and 82 controls were included. At baseline, all PWH were using antiretroviral therapy; 92.6% had undetectable HIV viral load (VL) and median CD4 + cell count was 630 cells...
YF vaccine is safe in PWH with CD4 + cell count ≥200 cells/μl. YF vaccine immunogenicity is impaired in PWH, particularly among those with high VL, low CD4 + cell count and low CD4 + /CD8 + ratio at v...
Malaria has been strongly linked to the transmission and pathophysiology of some viral diseases. Malaria and vaccine-preventable diseases often co-exist in endemic countries but the implication of the...
The malaria incidence, death due to malaria, measles and yellow fever data were sourced from the WHO database. Poisson and zero-inflated time-trend regression were used to model the relationships betw...
A significant negative relationship existed between malaria incidence and measles cases (P<0.05), however, malaria showed a positive relationship with yellow fever (P<0.05). The relationships between ...
Malaria varied negatively with measles cases but positively with yellow fever. The relationships observed in this study could be important for the management of malaria and the studied vaccine-prevent...
Yellow fever (YF) is an acute tropical infectious disease caused by an arbovirus and can manifest as a classic hemorrhagic fever. The mechanism of the bleeding diathesis in YF is not well understood. ...
Considering that vaccination with yellow fever vaccine (YFV) is the most important method to prevent and control yellow fever (YF), this study synthesized evidence on factors associated with YFV failu...
A systematic review (SR) was performed in the PubMed, Cochrane CENTRAL, Embase, and LILACS databases up to November 2019. Observational and experimental analytical epidemiological studies that analyze...
A total of 1,466 articles were identified after searching the databases of which 46 were included in the qualitative analysis after applying the elegibility criteria. Our findings indicated that YFV c...
The results of this SR revealed the factors associated with the failure of the YFV, and the results can support recommendations on vaccination policies, support the safety of health professionals who ...
To analyze the number of yellow fever vaccine doses administered before and during the covid-19 pandemic in Brazil....
This is an ecological, time series study based on data from the National Immunization Program. Differences between the median number of yellow fever vaccine doses administered in Brazil and in its reg...
We found a reduction in the median number of yellow fever vaccine doses administered in Brazil and in its regions: North (-34.71%), Midwest (-21.72%), South (-63.50%), and Southeast (-34.42%) (p < 0.0...
The reduced number of yellow fever vaccine doses administered during the covid-19 pandemic in Brazil may favor the reemergence of urban yellow fever cases in the country....
Yellow fever (YF), a non-contagious infectious disease, is endemic or enzootic to the tropical regions of the Americas and Africa. Periodic outbreaks or epidemics have a significant impact on public h...
Yellow fever (YF) is an infectious disease considered a public health problem in tropical and subtropical areas. YF has many pathophysiological events that are correlated with the host immune response...